0 CHECKOUT

Point of Care Diagnostic Testing World Markets

  • ID: 2569956
  • April 2016
  • Region: Global
  • 449 Pages
  • TriMark Publications
1 of 4
Point of Care Diagnostic Testing World Market to Jump to $15.9 Billion by 2018

FEATURED COMPANIES

  • A. Menarini Diagnostics
  • Ativa Medical Corporation
  • BiOracle
  • Exalenz Bioscience
  • Medica Corporation
  • Quidel Corporation
  • MORE

Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.

This report describes latest developments in the point of care testing market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor's offices. The study defines the dollar volume of point of care sales and makes five year projections - both in the U.S. and worldwide - including Europe, Asia and Latin America.

It also examines in detail the point of care sector for 25 individual country markets. A detailed summary of all important instruments in each READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • A. Menarini Diagnostics
  • Ativa Medical Corporation
  • BiOracle
  • Exalenz Bioscience
  • Medica Corporation
  • Quidel Corporation
  • MORE

1. Overview
1.1 About This Report
1.2 Scope of the Report
1.3 Objectives
1.4 Methodology
1.5 Executive Summary

2. Overview of Diagnostic Testing Point of Care Markets
2.1 Key Issues in the POC Diagnostic Testing Sector
2.1.1 Current Market Trends and Drivers
2.1.2 Effectiveness of POCT
2.1.3 New Growth Areas for POCT
2.1.4 Advantages of POCT in a Clinical Setting
2.1.5 Pricing and Reimbursement Issues
2.1.6 Key Customer Segments
2.2 Global Point of Care Marketplace
2.3 Shifts from Central Lab Testing to POCT
2.4 Geographical Distribution
2.5 Challenges of POCT
2.6 Key Issues for POCT
2.6.1 Locations of POCT
2.6.2 Milestones in Technology Development
2.6.3 Drive for Decentralization from Lab to Patient
2.6.4 Competitive Landscape for POCT
2.7 The Future of POCT

3. Summary Analysis of the Global POCT Market: Value, Growth Rates and Market Share
3.1 Global POCT Market
3.2 Global Market Revenues Analysis by Market Segment
3.2.1 Global POC Blood Glucose Monitoring Systems Market
3.2.2 Global POC Blood Gas and Electrolyte Analyzers Market
3.2.3 Global POC Rapid Coagulation Analyzers Market
3.2.4 Global POC Cardiac Markers Devices Market
3.2.5 Global POC Substance Abuse Testing Device Market
3.2.6 Global POC Infectious Disease Testing Device Market
3.2.7 Global POC Urine Strip Testing Market
3.2.8 Global POC Pregnancy Testing Device Market
3.2.9 Global POC Fecal Occult Device Market
3.2.10 Global POC Cholesterol Testing Market
3.3 Global Market Share Analysis
3.4 Global Market Size by Geographic Location
3.5 Global Market Size by Analyte Market Segment
3.6 Global POCT Testing by Location

4. Analysis of the U.S. POCT Market: Value, Growth Rates and Market Share
4.1 U.S. Market Revenues Analysis by Market Segment
4.1.1 U.S. POC Blood Glucose Monitoring Systems Market
4.1.2 U.S. POC Blood Gas and Electrolyte Analyzers Market
4.1.3 U.S. POC Rapid Coagulation Analyzers Market
4.1.4 U.S. POC Cardiac Markers Devices Market
4.1.5 U.S. POC Substance Abuse Testing Device Market
4.1.6 U.S. POC Infectious Disease Testing Device Market
4.1.7 U.S. POC Urine Strip Testing Market
4.1.8 U.S. POC Pregnancy Testing Device Market
4.1.9 U.S. POC Fecal Occult Device Market
4.1.10 U.S. POC Cholesterol Testing Market
4.2 U.S. Market Share Analysis
4.3 U.S. Market Size by Analyte Market Segment

5. Analysis of the European POCT Market: Value, Growth Rates and Market Shares
5.1 European Market Revenues Analysis
5.2 European Market Revenues Analysis by Geographic Region
5.2.1 French Revenues for POCT Systems
5.2.2 German Revenues for POCT Systems
5.2.3 Italian Revenues for POCT Systems
5.2.4 Spanish Revenues for POCT Systems
5.2.5 U.K. Revenues for POCT Systems
5.2.6 Benelux Revenues for POCT Systems
5.2.7 Scandinavian Revenues for POCT Systems
5.2.8 Rest of Europe Revenues for POCT Systems
5.3 European Market Revenues Analysis by Market Segment
5.3.1 European POC Blood Glucose Monitoring Systems Market
5.3.2 European POC Blood Gas and Electrolyte Analyzers Market
5.3.3 European POC Rapid Coagulation Analyzers Market
5.3.4 European POC Cardiac Marker Market
5.3.5 European POC Substance Abuse Testing Device Market
5.3.6 European POC Infectious Disease Testing Market
5.3.7 European POC Urine Strip Testing Market
5.3.8 European POC Pregnancy Testing Device Market
5.3.9 European POC Fecal Occult Blood Testing Market
5.3.10 European POC Cholesterol Testing Market
5.4 European Market Share Analysis

6. Analysis of the POCT Markets for Japan, China and India: Value, Growth Rates and Market Share
6.1 Summary Analysis of Japanese, Chinese and Indian POCT Market Revenues
6.2 Summary of Asian (Japanese, Chinese and Indian) Market Revenues by Market Segment
6.2.1 Asian (Japanese, Chinese and Indian) POC Blood Glucose Monitoring Systems Market
6.2.2 Asian (Japanese, Chinese and Indian) POC Blood Gas and Electrolyte Analyzers Market
6.2.3 Asian (Japanese, Chinese and Indian) POC Rapid Coagulation Analyzers Market
6.2.4 Asian (Japanese, Chinese and Indian) POC Cardiac Markers Devices Market
6.2.5 Asian (Japanese, Chinese and Indian) POC Substance Abuse Testing Device Market
6.2.6 Asian (Japanese, Chinese and Indian) POC Infectious Disease Testing Device Market
6.2.7 Asian (Japanese, Chinese and Indian) POC Urine Strip Testing Market
6.2.8 Asian (Japanese, Chinese and Indian) POC Pregnancy Testing Device Market
6.2.9 Asian (Japanese, Chinese and Indian) POC Fecal Occult Device Market
6.2.10 Asian (Japanese, Chinese and Indian) POC Cholesterol Testing Market
6.3 Asian (Japanese, Chinese and Indian) Market Share Analysis
6.4 Summary Analysis of the Japanese POCT Market
6.5 Summary Analysis of the Indian POCT Market
6.6 Summary Analysis of the Chinese POCT Market

7. Analysis of the Rest of World (ROW) POCT Market: Value, Growth Rates and Market Share
7.1 Summary Analysis of the ROW POCT Market Revenues
7.2 Summary of the ROW Market Revenues by Market Segment
7.2.1 ROW POC Blood Glucose Monitoring Systems Market
7.2.2 ROW POC Blood Gas and Electrolyte Analyzers Market
7.2.3 ROW POC Rapid Coagulation Analyzers Market
7.2.4 ROW POC Cardiac Markers Devices Market
7.2.5 ROW POC Substance Abuse Testing Device Market
7.2.6 ROW POC Infectious Disease Testing Device Market
7.2.7 ROW POC Urine Strip Testing Market
7.2.8 ROW POC Pregnancy Testing Device Market
7.2.9 ROW POC Fecal Occult Device Market
7.2.10 ROW POC Cholesterol Testing Market
7.3 ROW Market Share Analysis
7.4 Summary Analysis of the ROW POCT Market Revenues
7.4.1 Summary Analysis of the Argentinian POCT Market
7.4.2 Summary Analysis of the Australian POCT Market
7.4.3 Summary Analysis of the Brazilian POCT Market
7.4.4 Summary Analysis of the Canadian POCT Market
7.4.5 Summary Analysis of the Russian POCT Market
7.4.6 Summary Analysis of the Middle East POCT Market
7.4.7 Summary Analysis of the African POCT Market
7.4.8 Summary Analysis of the Asia-Pacific POCT Market

8. Review of the Market Segments, Reagents and Equipment
8.1 Blood Glucose Monitoring
8.1.1 Introduction to Blood Glucose Monitoring
8.1.2 Types of Blood Glucose Testing
8.1.2.1 Fasting Blood Sugar (FBS) or Fasting Plasma Glucose (FPG)
8.1.2.2 Two-Hour Postprandial Blood Sugar or Two-Hour PC
8.1.2.3 Random Blood Sugar (RBS)
8.1.2.4 Glucose Urine Test
8.1.2.5 Blood Glucose Test Strip
8.1.2.6 Glycosylated Hemoglobin (HbA1c)
8.1.2.7 Intravenous Glucose Tolerance Test (IVGTT)
8.1.2.8 Oral Glucose Tolerance Test (OGTT)
8.1.3 Segmentation of POC Blood Glucose Testing
8.1.3.1 Continuous Blood Glucose Monitoring (CBGM)
8.1.3.2 Self-Monitoring Blood Glucose (SMBG) Testing
8.1.3.3 Minimally-Invasive and Non-Invasive Blood Glucose Testing
8.1.3.4 Emerging Glucose Monitoring Technologies
8.1.3.5 Optical Transducer Technologies
8.1.3.6 Transdermal Sensor Technologies
8.1.3.7 Invasive Glucose Sensor Technologies
8.1.4 Review of Professional POC Blood Glucose Monitoring Systems
8.1.4.1 New Guidance: Use of Blood Glucose Monitoring Systems for Professional and Home POC
8.1.5 Review of POC Blood Glucose Monitoring Products
8.1.5.1 Abaxis, Inc.
8.1.5.2 Abbott
8.1.5.3 Alere
8.1.5.4 Apex Biotechnology
8.1.5.5 ARKRAY, Inc.
8.1.5.6 DiaSys
8.1.5.7 EKF Diagnostics
8.1.5.8 Fora Care
8.1.5.9 HemoCue (part of Radiometer)
8.1.5.10 HMD BioMedical
8.1.5.11 Infopia
8.1.5.12 Instrumentation Laboratory
8.1.5.13 Jant Pharmacal
8.1.5.14 LifeHealth (formerly International Technidyne Corp.)
8.1.5.15 Medtronic
8.1.5.16 Nova Biomedical
8.1.5.17 Polymer Technology Systems
8.1.5.18 Radiometer
8.1.5.19 Randox Laboratories
8.1.5.20 Roche
8.1.5.21 Siemens
8.1.5.22 Stanbio Laboratory
8.1.5.23 Techno Medica Co., Ltd.
8.1.5.24 LifeScan
8.1.6 Professional POC Hemoglobin A1c (HbA1c) Testing
8.1.6.1 A. Menarini Diagnostics
8.1.6.2 Alere
8.1.6.3 Apex Biotechnology
8.1.6.4 Convergent Technologies GmbH & Co.
8.1.6.5 DiaSys Diagnostic Systems
8.1.6.6 Diazyme Laboratories
8.1.6.7 EKF Diagnostics
8.1.6.8 Eurolyser
8.1.6.9 Green Cross Medis (formerly Ceragem Medisys)
8.1.6.10 HemoCue (a division of Radiometer)
8.1.6.11 Infopia
8.1.6.12 Roche
8.1.6.13 SD Biosensor
8.1.6.14 Siemens Healthcare Diagnostics
8.1.6.15 Erba Diagnostics
8.1.7 Market Analysis
8.1.7.1 Worldwide Professional Glucose Testing Market
8.1.7.2 U.S. Professional Glucose Testing Market
8.1.8 Competitive Analysis for the Glucose POCT Sector
8.1.9 Market Share for Glucose Testing
8.1.10 Competitive Analysis for the Glucose POCT Sector
8.1.11 Market Analysis
8.1.11.1 Market Drivers
8.1.11.2 Market Restraints
8.1.12 POC Glucose Testing Assay Market and Technology Trends
8.1.12.1 POC Glucose Testing Assay Market Trends
8.1.12.2 POC Glucose Testing Assay Technology Trends
8.1.12.3 POC Glucose Testing Assay Strategic Recommendations
8.2 Blood Gas and Electrolytes
8.2.1 Background to POC Blood Gas and Electrolyte Testing
8.2.1.1 Acid-Base Balance and the Lungs
8.2.1.2 Respiratory Acidosis
8.2.1.3 Respiratory Alkalosis
8.2.1.4 Metabolic (or Non-Respiratory) Acidosis
8.2.1.5 Metabolic (or Non-Respiratory) Alkalosis
8.2.1.6 Increasing Popularity of POC Blood Gas and Electrolyte Testing
8.2.2 Market Segmentation (Segmentation by Type of Blood Gas Monitoring Equipment)
8.2.2.1 Intermittent Blood Gas Monitoring Equipment
8.2.2.2 Continuous Blood Gas Monitoring Equipment
8.2.2.3 EABG Monitors
8.2.2.4 IABG Monitors
8.2.2.5 Portable Blood Gas Analyzers
8.2.2.6 Patient-Attached On-Demand Blood Gas Analyzers
8.2.3 Applications for POCT Blood Gas and Electrolyte Analyzers
8.2.4 Emerging Technologies
8.2.5 Whole-Blood Lactate
8.2.6 Creatinine
8.2.7 Electrolytes Point of Care Analysis: Comparison of POCT and Central Lab Results
8.2.8 Review of Selected Blood Gas and Electrolyte Analyzers
8.2.9 Review of Company Products
8.2.9.1 Roche Corporation
8.2.9.2 Siemens Healthcare Diagnostics
8.2.9.3 Instrumentation Laboratory
8.2.9.4 Nova Biomedical
8.2.9.5 Radiometer
8.2.9.6 Abbott Point of Care
8.2.9.7 Accriva Diagnostics
8.2.9.8 Alere
8.2.9.9 Opti Medical
8.2.10 Market Share for Blood Gas and Electrolyte Testing
8.2.11 Market Analysis
8.2.11.1 Market Drivers
8.2.11.2 Market Restraints
8.2.12 POC Blood Gas and Electrolyte Testing Assay Market and Technology Trends
8.2.12.1 POC Blood Gas and Electrolyte Testing Assay Market Trends
8.2.12.2 POC Blood Gas and Electrolyte Testing Assay Technology Trends
8.2.12.3 POC Blood Gas and Electrolyte Testing Assay Strategic Recommendations
8.3 Rapid Coagulation Tests
8.3.1 Background to Rapid Coagulation Tests
8.3.2 Review of Selected POC Rapid Coagulation Analyzers
8.3.3 Review of Company Products
8.3.3.1 Roche Diagnostics Corp.
8.3.3.2 Abbott Laboratories
8.3.3.3 Accriva
8.3.3.4 Medtronic
8.3.3.5 Alere
8.3.3.6 Helena Laboratories Point of Care
8.3.3.7 Sienco, Inc.
8.3.3.8 Instrumentation Laboratory’s GEM PCL Plus
8.3.4 Connectivity Issues
8.3.5 Cost Benefits
8.3.6 Quality Control Issues
8.3.7 Certification for POC Coagulation Devices
8.3.8 D-Dimer Testing
8.3.9 Market Analysis
8.3.9.1 Market Share for POCT Coagulation Testing
8.3.9.2 Competitive Analysis of Sector Companies
8.3.9.3 Market Drivers
8.3.9.4 Market Restraints
8.3.9.5 POC Coagulation Testing Assay Market Trends
8.3.9.6 POC Coagulation Testing Assay Technology Trends
8.3.9.7 POC Coagulation Testing Assay Strategic Recommendations
8.3.9.8 SWOT Analysis: Summary of Strengths, Weaknesses, Opportunities and Threats in the Coagulation POC Market
8.4 POC Rapid Cardiac Markers
8.4.1 Background to POC Rapid Cardiac Marker Testing
8.4.2 Cardiac Marker Tests
8.4.2.1 Creatine Kinase (CK)
8.4.2.2 Myoglobin
8.4.2.3 Cardiac Troponins T (TnT), I (TnI) and C (TnC)
8.4.2.4 C-Reactive Protein (CRP)
8.4.2.5 Homocysteine
8.4.3 Emerging Markers
8.4.3.1 B-Type Natriuretic Peptide (BNP)
8.4.3.2 Myeloperoxidase (MPO)
8.4.3.3 Ischemia-Modified Albumin (IMA)
8.4.3.4 Glycogen Phosphorylase Isoenzyme BB (GPBB)
8.4.3.5 Fatty Acid-Binding Proteins (FABPs)
8.4.4 Review of Selected POC Cardiac Biomarker Analyzers
8.4.5 Review of Company Products
8.4.5.1 Abbott’s i-STAT System
8.4.5.2 Alere’s Triage System
8.4.5.3 Alpha Scientific
8.4.5.4 Boditech Med’s i-CHROMA System
8.4.5.5 BTNX
8.4.5.6 Homemed
8.4.5.7 LSI Medience (formerly Mitsubishi Chemical Medience Corp.)
8.4.5.8 Nano-Ditech
8.4.5.9 Princeton BioMeditech
8.4.5.10 Radiometer (part of Danaher)
8.4.5.11 Response Biomedical Corporation
8.4.5.12 Roche Diagnostics’ cobas h 232 POC System
8.4.5.13 Roche’s CARDIAC TROP T Sensitive Test (Visual)
8.4.5.14 Siemens Healthcare Diagnostics (f/k/a Bayer Healthcare Diagnostics, Diagnostic Products Corporation and Dade Behring)
8.4.5.15 Trinity Biotech
8.4.5.16 Trivitron Healthcare (formerly Ani Biotech)
8.4.5.17 bioMérieux
8.4.6 Market Share and Sales for Cardiac Marker Testing
8.4.6.1 Market Drivers
8.4.6.2 Market Restraints
8.4.7 POC Cardiac Marker Testing Assay Market and Technology Trends
8.4.7.1 POC Cardiac Marker Testing Assay Market Trends
8.4.7.2 POC Cardiac Marker Testing Assay Technology Trends
8.4.7.3 POC Cardiac Marker Testing Assay Strategic Recommendations
8.5 POCT Substance Abuse Testing
8.5.1 Background to POC Substance Abuse Testing
8.5.2 Substance Abuse Test Types
8.5.2.1 Urine Substance/Drug Screening
8.5.2.2 Hair Tests for Substance Abuse and Screening
8.5.2.3 Blood Tests for Substance Abuse and Screening
8.5.2.4 Saliva Tests for Substance Abuse and Screening
8.5.2.5 Sweat Tests for Substance Abuse and Screening
8.5.3 Alcohol Abuse and Screening
8.5.4 Saliva Testing
8.5.5 Qualitative Analysis
8.5.5.1 Market Drivers
8.5.5.2 Market Restraints
8.5.6 Review of Selected POC Substance Abuse Analyzers
8.5.7 Review of Company Products
8.5.7.1 Alere
8.5.7.2 Abbott Diagnostics
8.5.7.3 BTNX, Inc.
8.5.7.4 BioScan Screening Systems, Inc.
8.5.7.5 American Bio Medica Corp.
8.5.7.6 Phamatech, Inc.
8.5.7.7 First Check Diagnostics Corp. (Alere, Inc.)
8.5.7.8 OraSure
8.5.7.9 Noble Medical, Inc.
8.5.7.10 Guangzhou Wondfo Biotech Co., Ltd.
8.5.7.11 Pathtech
8.5.7.12 Alfa Scientific Designs, Inc.
8.5.7.13 American Bio Medica
8.5.7.14 Biophor Diagnostics
8.5.7.15 Randox Laboratories
8.5.7.16 Branan Medical
8.5.7.17 Concateno
8.5.7.18 LifeSign
8.6 POC Pregnancy and Fertility Tests
8.6.1 Background to POC Pregnancy and Fertility Tests
8.6.2 Review of Selected POC Pregnancy Testing Devices
8.6.3 Review of Company Products
8.6.3.1 Quidel
8.6.3.2 Abbott Diagnostics
8.6.3.3 Alere
8.6.3.4 Sutherland Health Group Ltd.
8.6.3.5 Sekisui Diagnostics, LLC
8.6.3.6 Siemens Diagnostics
8.6.3.7 Orgenics (A subsidiary of Alere)
8.6.3.8 LifeSign
8.6.3.9 Other Companies in this Sector
8.6.3.10 Market Analysis
8.6.3.10.1 Competitive Sector Analysis
8.7 Fecal Occult Blood
8.7.1 Background to POC Fecal Occult Blood Testing
8.7.2 Review of Selected POC Fecal Occult Testing Devices
8.7.3 Review of Company Products
8.7.3.1 Helena Laboratories
8.7.3.2 Biomerica
8.7.3.3 Beckman Coulter
8.7.3.4 Worldwide Medical
8.7.3.5 Aerscher Diagnostics
8.7.3.6 Enterix
8.7.3.7 Medix Biochemica
8.7.3.8 Orion Diagnostica
8.7.3.9 ACON Laboratories’ Mission FOB Reagent Strips
8.7.3.10 Alere’s Products
8.7.3.11 Immunostics Hema-Screen
8.7.3.12 Princeton BioMeditech’s BioSign iFOBTest
8.7.3.13 Quest Diagnostics’ InSure FIT
8.7.3.14 Quidel’s QuickVue iFOB
8.7.3.15 Exact Sciences’ Cologuard
8.7.3.16 Epigenomics
8.7.3.17 CTK Biotech
8.7.4 Market Share for Fecal Occult Blood Testing
8.7.4.1 Company Analysis for the Fecal Occult Blood POCT Sector
8.7.5 Market Analysis
8.7.5.1 Market Drivers
8.7.5.2 Market Restraints
8.7.5.3 POC Fecal Occult Blood Testing Assay Market and Technology Trends
8.7.5.3.1 POC Fecal Occult Blood Testing Assay Market Trends
8.7.5.3.2 Fecal Occult Blood Testing Assay Technology Trends
8.7.5.3.3 POC Fecal Occult Blood Testing Assay Strategic Recommendations
8.8 POC Infectious Disease Testing
8.8.1 Background to POC Infectious Disease Testing
8.8.2 Types of Diagnosis for Infectious Diseases
8.8.2.1 Microbial Culture
8.8.2.2 Microscopy
8.8.2.3 Biochemical Tests
8.8.2.4 Immunologic Tests
8.8.2.5 Molecular Diagnostics Testing
8.8.3 Diagnostic Platforms for Infectious Diseases
8.8.3.1 Centralized Laboratory Testing for Infectious Diseases
8.8.3.2 POC Testing for Infectious Diseases
8.8.4 Emerging Technologies
8.8.5 Market Analysis
8.8.5.1 Market Drivers
8.8.5.2 Market Restraints
8.8.6 Review of Selected POC Infectious Disease Testing Devices
8.8.6.1 POC Infectious Disease Testing Devices and Assays in Development
8.8.6.1.1 Cepheid’s GeneXpert Omni
8.8.6.1.2 Alere q
8.8.6.1.3 Quidel
8.8.6.1.4 Roche’s cobas Liat System
8.8.6.1.5 QuantuMDx’s Q-POC
8.8.6.1.6 SRI International
8.8.6.1.7 Atlas Genetics’ io System
8.8.7 Overview of POC Assays for Detection of Infectious Disease
8.8.7.1 Anthrax and Other Bio-threats
8.8.7.2 Campylobacter
8.8.7.3 Clostridium difficile
8.8.7.4 E. coli
8.8.7.5 Gastrointestinal Infectious Agents
8.8.7.5.1 Giardia and Cryptosporidium
8.8.7.5.2 Entamoeba histolytica
8.8.7.5.3 Rotavirus & Adenovirus
8.8.7.5.4 Norovirus
8.8.7.6 Hepatitis
8.8.7.7 Herpes Simplex Virus Type-2
8.8.7.8 Influenza
8.8.7.9 Legionella
8.8.7.10 Malaria Testing
8.8.7.11 Meningitis
8.8.7.12 Mononucleosis
8.8.7.13 Procalcitonin (Detects Sepsis)
8.8.7.14 Respiratory Tract Infections
8.8.7.14.1 C-Reactive Proteins
8.8.7.14.2 Pneumonia
8.8.7.14.3 Respiratory Tract Panels
8.8.7.15 RSV
8.8.7.16 Streptococcus
8.8.7.17 Rubella
8.8.7.18 Sexually-Transmitted Diseases
8.8.7.18.1 Chlamydia
8.8.7.18.2 Gonorrhea Testing
8.8.7.18.3 Syphilis
8.8.7.19 Staphylococcus aureus and MRSA
8.8.7.20 Streptococcus A Testing
8.8.7.21 Tropical Diseases
8.8.7.21.1 Chagas Disease
8.8.7.21.2 Dengue Fever
8.8.7.21.3 Ebola
8.8.7.21.4 Filariasis
8.8.7.21.5 Onchocerciasis
8.8.7.21.6 Zika Virus
8.8.7.22 Tuberculosis
8.8.7.23 Typhoid
8.9 POC Urine Strip Testing
8.9.1 Background to POC Urine Strip Testing
8.9.2 Emerging Technologies
8.9.3 Review of Selected POC Urine Strip Testing Devices
8.10 POC Cholesterol Testing
8.10.1 POC Cholesterol Testing Market Size and Development
8.10.2 Background to POC Cholesterol Testing
8.10.3 POC Cholesterol Testing Devices
8.10.3.1 Review of Selected POC Cholesterol Testing Devices
8.10.4 Review of Company Products
8.10.4.1 Cholestech (Now Alere)
8.10.4.2 Polymer Technology Systems
8.10.4.3 Miraculins
8.10.4.4 Abaxis, Inc.
8.10.5 Product Comparison of Leading Suppliers
8.10.6 Launch Dates of Leading Products Worldwide
8.11 Miscellaneous POC Tests
8.11.1 Estriol
8.11.2 POC H. pylori Testing
8.11.3 Bacterial Contamination of Platelet Units
8.11.4 POC Vaginal Fluid pH and Vaginitis Testing
8.11.5 POC Cancer Testing
8.11.5.1 Prostate-Specific Antigen (PSA)
8.11.5.2 Bladder Cancer
8.11.5.3 Other Rapid Cancer Tests
8.11.6 Fetal Status (PROM)
8.11.7 Hemodynamic Monitoring
8.11.8 Heparin-Induced Thrombocytopenia
8.11.9 Ruptured Fetal Membranes
8.11.10 Alcohol
8.11.12 Microalbumin Testing
8.11.13 Prenatal, Labor and Delivery Testing
8.11.13.1 Alere Triage PLGF
8.11.13.2 Medix Biochemica
8.11.14 Sperm Fertility
8.11.15 Surgical Coagulation and Hemostasis Management
8.11.16 Respiratory Tests
8.11.17 C-Reactive Protein
8.12 HIV
8.12.1 FDA-Approved Rapid HIV Assays
8.12.1.1 Alere
8.12.1.2 bioLytical Laboratories, Inc.
8.12.1.3 Bio-Rad Laboratories
8.12.1.4 Chembio Diagnostics
8.12.1.5 MedMira Laboratories, Inc.
8.12.1.6 OraSure Technologies
8.12.1.7 Trinity Biotech
8.12.2 Rapid HIV Assays Not Approved by the FDA (not commercially available in the U.S.)
8.12.2.1 Alere
8.12.2.2 bioMérieux
8.12.2.3 Bio-Rad
8.12.2.4 Core Diagnostics
8.12.2.5 CTK Biotech
8.12.2.6 EY Laboratories
8.12.2.7 Hema Diagnostics Systems
8.12.2.8 ImmunoScience
8.12.2.9 InTec Products
8.12.2.10 JAL Innovation
8.12.2.11 J Mitra & Co.
8.12.2.12 Premier Medical Corporation
8.12.2.13 Princeton BioMeditech
8.12.2.14 Savyon Diagnostics
8.12.2.15 Shanghai Kehua
8.12.2.16 Span Diagnostics
8.12.2.17 Tulip Group
8.12.2.18 YD Diagnostics’ AIDScan
8.12.3 POC Viral Load Technologies of the Future
8.12.3.1 Cepheid
8.12.3.2 Roche
8.12.3.3 Wave 80 Biosciences

9. POCT: Growth Regulators
9.1 Moderators of Growth
9.2 Personnel Acceptance
9.3 Key People for POCT
9.4 Information Management Issues
9.4.1 Elements of Information Management for POCT: Information-Processing Capabilities
9.4.2 Data Mining
9.4.3 Middleware
9.4.4 Web Portals
9.4.5 POCT-1A Standard
9.5 Key Elements for POCT
9.6 POCT and Reimbursement
9.7 Effectiveness of Clinical Outcomes
9.8 Rapid Near-Patient Testing in Hospitals
9.9 Satellite Facilities
9.10 Regionalization of Laboratory Care
9.11 Requirements for POCT
9.12 Locations of POC for Patient Care
9.13 Benefits of POCT
9.14 Cost Elements of POCT
9.15 Necessary Functions in POCT
9.16 Turnaround Time (TAT) for POCT
9.17 Clinical Laboratory Improvement Amendments (CLIA)
9.18 Sexually-Transmitted Diseases in Underdeveloped Countries
9.19 Sources of Error in POC Testing

10. Business Trends in the POC Sector
10.1 Sector Consolidation
10.2 Diagnostic Testing Growth Trends
10.2.1 Opportunities for Healthcare Stakeholders
10.3 Acquisition, License Agreements, Internal Development and Partnerships
10.4 Product Testing Depth in POCT
10.5 Government Regulation
10.5.1 U.S. Regulation
10.5.1.1 Importing Medical Devices into the U.S.
10.5.1.2 Exporting Medical Devices from the U.S.
10.5.2 E.U. Regulation
10.5.3 Japanese Regulation
10.6 Post-Filing Regulations for POC Devices
10.7 Exporting Unapproved POCTs
10.8 Analyte-Specific Reagents (“Home-Brew” Tests)
10.9 Medical Device Registration
10.10 Product Labeling
10.11 Punitive FDA Actions
10.12 CLIA ‘88 and State Laboratory Laws
10.13 Impact of Regulations on the Industry
10.14 Minimizing Regulatory Barriers
10.15 Waived Testing

11. Technology Platform Innovations in POCT
11.1 Latest POCT Technological Platforms
11.1.1 Device Miniaturization and Microfluidic Technologies
11.1.2 Minimally-Invasive and Non-Invasive POCT Technologies
11.1.2.1 Libre Flash Glucose Monitor and OneTouch Verio Sync Meter
11.1.2.2 Echo Therapeutics
11.1.3 Advances in Wireless Technologies
11.1.4 Automation of POCT
11.1.5 Developments in New Genomic Technologies (Genotyping, Haplotyping and Sequencing
Technologies)
11.1.6 Advances in Informatics Technologies
11.1.7 Pharmacogenetic Testing
11.1.8 Multi-Assay Technologies in POCT
11.1.9 Molecular Diagnostic Technology in POCT for Infectious Disease
11.2 Smart Phone Technology
11.2.1 Aquila Diagnostic Systems, Inc.
11.2.2 AgaMatrix
11.2.3 Quick HIV and Syphilis Screening
11.2.4 Accu-Check Connect System
11.3 QuantuMDx Handheld, Portable Low Cost Rapid Devices

12. Data Management and Connectivity
12.1 Wireless LANs
12.2 Connectivity Platforms
12.2.1 Data Management Systems
12.2.1.1 Alere RALS System
12.2.1.2 International Technidyne Corporation HEMOCHRON Signature Elite
12.2.1.3 Siemens Diagnostics Rapidpoint
12.2.1.4 Radiometer
12.2.1.5 HemoCue’s DM Hemoglobin
12.2.1.6 Roche Diagnostics Cobas IT
12.2.1.7 Accriva
12.2.3 BD.id
12.2.4 Medical Implant Communications Service (MICS)
12.2.5 Conworx Technology
12.2.6 Telcor QML
12.2.7 Medasys
12.2.8 NoemaLife
12.2.9 Telcare
12.3 Advantages of POCT Connectivity
12.3.1 Cost-Benefit Analysis of POCT and IT Connectivity
12.3.2 Hospital Network Issues

13. Corporate Profiles
13.1 Abaxis, Inc.
13.2 Abbott Laboratories
13.3 AccuBioTech Co., Ltd.
13.4 Accriva Diagnostics
13.5 ACON Laboratories, Inc.
13.6 Acrongenomics
13.7 AgaMatrix
13.8 Aerscher Diagnostics, LLC
13.9 Akers Biosciences, Inc.
13.10 Alere
13.11 Alfa Scientific Designs, Inc.
13.12 American Bio Medica Corporation
13.13 Arkray, Inc.
13.14 Atlas Genetics Ltd.
13.15 Atonomics A/S
13.16 Audit Diagnostics
13.17 Augurix Diagnostics Ltd.
13.18 Axxin
13.19 Beckman Coulter (Danaher Corporation)
13.20 bioLytical Laboratories
13.21 Biomerica, Inc.
13.22 bioMérieux
13.23 BiOracle
13.24 Bio-Rad Laboratories, Inc.
13.25 BioScan Screening Systems, Inc.
13.26 Calypte Biomedical Corporation
13.27 Chembio Diagnostic, Inc.
13.28 Cholestech
13.29 Claros Diagnostics (OPKO Healthcare)
13.30 ERBA Diagnostics, Inc.
13.31 Daktari Diagnostics
13.32 Dexcom
13.33 Diagnostics for All
13.34 Enigma Diagnostics Ltd.
13.35 EY Laboratoires, Inc.
13.36 Eurotrol
13.37 Exalenz Bioscience
13.38 GenBio
13.39 Guided Therapeutics, Inc.
13.40 Helena Laboratories
13.41 Hema Diagnostic Systems, LLC
13.42 Instrumentation Laboratory (IL)/Werfen Group
13.43 Jant Pharmacal Corporation
13.44 Lein Applied Diagnostics
13.45 LifeSign, LLC
13.46 Medica Corporation
13.47 Medix Biochemica
13.48 MedMira Laboratories
13.49 A. Menarini Diagnostics
13.50 Micronics
13.51 New Horizons Diagnostics
13.52 Nova Biomedical
13.53 OraSure Technologies, Inc.
13.54 Orion Diagnostica
13.55 Polymedco, Inc.
13.56 Polymer Technology Systems, Inc.
13.57 Prima Biomedical Company
13.58 Qualigen
13.59 Quest Diagnostics, Inc.
13.60 Quidel Corporation
13.61 Radiometer Medical
13.62 Response Biomedical Corp.
13.63 Roche Diagnostics
13.64 Savyon Diagnostics
13.65 Seegene
13.66 Sekisui Diagnostics, LLC
13.67 Shanghai Ruicare Medical Co., Ltd.
13.68 Shenzhen Fitconn Technology Co., Ltd.
13.69 Shionogi & Co., Ltd.
13.70 Siemens AG
13.71 Siloam Biosciences, Inc.
13.72 Spectral Diagnostics, Inc.
13.73 StatSure Diagnostic Systems, Inc.
13.74 One Step Detect Associates, LLC
13.75 Senseonics
13.76 Telcare
13.77 Trinity Biotech Plc
13.78 Väsamed, Inc.

14. POCT Sector Trends and Forecasts
14.1 Home Care Analysis as Part of Near-Patient Testing
14.2 Non-Traditional Collection for POCT
14.3 New Systems for Critical Care and Near-Patient Testing
14.4 Utility of Near-Patient Testing in Critical-Care Settings
14.5 Physician’s Office Market
14.6 Information Management Advances
14.7 Test-Ordering Patterns and Demand for POCT
14.8 Demand for Emergency Department Services
14.9 Move Away from the Central Laboratory
14.10 Healthcare Cost Controls
14.11 Mergers & Acquisitions
14.12 Competition for Services
14.13 Drivers of POCT
14.14 Confluence of New Technology
14.15 Difficulties of Design for POC Products
14.16 Point of Care Compliance
14.17 The Biggest New Opportunities in POCT

15. New Entrants to the Point of Care Market
15.1 Alliance International Co., Ltd.
15.2 Analyticon Biotechnologies AG
15.3 Ativa Medical Corporation
15.4 Aquila Diagnostic Systems, Inc.
15.5 ArcDia International Oyo Ltd.
15.6 Artron Laboratories, Inc.
15.7 Atlas Link Biotech Co., Ltd.
15.8 Audit Diagnostics
15.9 Autobio Diagnostics Co., Ltd.
15.10 Biocartis SA
15.11 BioFire Diagnostics, Inc.
15.12 BioMedomics
15.13 Biosensia Ltd.
15.14 Curetis AG
15.15 DxNA, LLC
15.16 Echo Therapeutics, Inc.
15.17 Gentag, Inc.
15.18 Great Basin Corporation
15.19 Immunexpress Group
15.20 Integrated Diagnostics
15.21 Integrity Applications
15.22 MBio Diagnostics, Inc.
15.23 Menssana Research, Inc.
15.24 Metaara Medical Technologies, Inc.
15.25 QuantuMDx Group
15.26 Venaxis, Inc.
15.27 Philips Business Group EBA
15.28 Wave 80 Biosciences
15.29 Veredus Laboratories Pte Ltd.

Index Of Figures

Figure 2.1: Worldwide Distribution of IVD Testing, 2015
Figure 2.2: Top 13 Country IVD Testing Markets, 2015
Figure 2.3: Market Share for IVD Testing by Company, 2015
Figure 3.1: Total Global POCT Market, 2008-2018
Figure 3.2: Worldwide Distribution of POCT, 2015
Figure 3.3: Summary of Global POCT Markets by Market Segment, 2015
Figure 4.1: U.S. Revenues for POCT Market, 2008-2018
Figure 4.2: Summary of U.S. POCT Markets by Market Segment, 2015
Figure 5.1: European Revenues for POCT Market, 2008-2018
Figure 6.1: Summary Analysis of Japanese, Chinese and Indian POCT Market, 2008-2018
Figure 6.2: Japanese Revenues for POCT Market, 2008-2018
Figure 6.3: Indian Revenues for POCT Market, 2008-2018
Figure 6.4: Chinese Revenues for POCT Market, 2008-2018
Figure 7.1: Summary Analysis of ROW POCT Market, 2008-2018
Figure 7.2: Summary Analysis of Russian Revenues for POCT Products Market, 2008-2018
Figure 7.3: Summary Analysis of Middle East Revenues for POCT Products Market, 2008-2018
Figure 7.4: Summary Analysis of African Revenues for POCT Products Market, 2008-2018
Figure 7.5: Summary Analysis of Latin America Revenues for POCT Products Market, 2008-2018
Figure 8.1: Global Share of Glucose Testing Market by Company, 2015
Figure 8.2: Global POCT Share of Blood Gas and Electrolyte Testing Market, 2015
Figure 8.3: Global POCT Share of Coagulation Testing Market, 2015
Figure 8.4: Global POCT Share of Cardiac Marker Testing Market, 2015
Figure 8.5: Distribution of Infectious Diseases Tested at the Point of Care
Figure 8.6: Global POCT Share of HIV Testing Market, 2015
Figure 9.1: Annual Rate of Emergency Room Visits by Primary Expected Source of Payment
Figure 10.1: Conformity Assessment Route, Annexes and Quality System Standards by IVD Device Category
Figure 12.1: The Alere RALS Data Management System Connects to Most of the Major Instruments Used in Point of Care

Index Of Tables

Table 2.1: Summary of Global POCT Markets by Major Market Sub-Segment, 2015 and 2018
Table 2.2: Summary of U.S. POCT Markets by Major Market Sub-Segment, 2015 and 2018
Table 2.3: Summary of European POCT Markets by Major Market Sub-Segment, 2015 and 2018
Table 2.4: Summary of Asian POCT Markets by Major Market Sub-Segment, 2015 and 2018
Table 2.5: Summary of ROW POCT Markets by Major Market Sub-Segment, 2015 and 2018
Table 2.6: Worldwide Distribution of IVD Testing, 2015
Table 2.7: Top 13 Country IVD Testing Markets, 2015
Table 2.8: Company Market Share for IVD Testing Markets, 2015
Table 2.9: Competitive Landscape for POC Diagnostic Testing
Table 3.1: Total Global POCT Market, 2008-2018
Table 3.2: Global Revenues for POC Blood Glucose Monitoring Systems, 2008-2018
Table 3.3: Global Revenues for POC Blood Gas and Electrolyte Analyzers, 2008-2018
Table 3.4: Global Revenues for POC Rapid Coagulation Analyzer Systems, 2008-2018
Table 3.5: Global Revenues for POC Cardiac Marker Devices, 2008-2018
Table 3.6: Global Revenues for POC Substance/Drug Abuse Testing Device Market, 2008-2018
Table 3.7: Global Revenues for POC Infectious Disease Testing Devices Market, 2008-2018
Table 3.8: Global Revenues for POC Urine Strip Testing Products Market, 2008-2018
Table 3.9: Global Revenues for POC Pregnancy Testing Devices Market, 2008-2018
Table 3.10: Global Revenues for POC Fecal Occult Testing Devices Market, 2008-2018
Table 3.11: Global Revenues for POC Cholesterol Testing Products Market, 2008-2018
Table 3.12: Global POCT Market Share Analysis, 2015
Table 3.13: Worldwide POCT Market Size by Geographic Location, 2008-2018
Table 3.14: Worldwide Distribution of POCT, 2015
Table 3.15: Summary of Global POCT Markets by Market Segment, 2015
Table 3.16: Worldwide POCT by Performance Location, 2015
Table 4.1: U.S. Revenues for POCT Market, 2008-2018
Table 4.2: U.S Revenues for POC Blood Glucose Monitoring Systems, 2008-2018
Table 4.3: U.S. Revenues for POC Blood Gas and Electrolyte Analyzers, 2008-2018
Table 4.4: U.S. Revenues for POC Rapid Coagulation Analyzer Systems, 2008-2018
Table 4.5: U.S. Revenues for POC Cardiac Marker Devices, 2008-2018
Table 4.6: Market Share of U.S. POCT Cardiac Marker Market, 2015
Table 4.7: U.S. Revenues for POC Substance/Drug Abuse Testing Device Market, 2008-2018
Table 4.8: U.S. Revenues for POC Infectious Disease Testing Devices Market, 2008-2018
Table 4.9: U.S. Revenues for POC Urine Strip Testing Products Market, 2008-2018
Table 4.10: U.S. Revenues for POC Pregnancy Testing Devices Market, 2008-2018
Table 4.11: U.S. Revenues for POC Fecal Occult Testing Devices Market, 2008-2018
Table 4.12: U.S. Revenues for POC Cholesterol Testing Products Market, 2008-2018
Table 4.13: U.S. POCT Market Share Analysis, 2015
Table 4.14: Summary of U.S. POCT Markets by Market Segment, 2015
Table 5.1: Models of Public-Private Partnership in Hospital Provision
Table 5.2: European Revenues for POCT Market, 2008-2018
Table 5.3: French Revenues for POCT Systems, 2008-2018
Table 5.4: German Revenues for POCT Systems, 2008-2018
Table 5.5: Italian Revenues for POCT Systems, 2008-2018
Table 5.6: Spanish Revenues for POCT Systems, 2008-2018
Table 5.7: U.K. Revenues for POCT Systems, 2008-2018
Table 5.8: Benelux Revenues for POCT Systems, 2008-2018
Table 5.9: Scandinavian Revenues for POCT Systems, 2008-2018
Table 5.10: Rest-of-Europe Revenues for POCT Systems, 2008-2018
Table 5.11: European Revenues for POC Blood Glucose Monitoring Systems, 2008-2018
Table 5.12: European Revenues for POC Blood Gas and Electrolyte Analyzers, 2008-2018
Table 5.13: European Revenues for POC Rapid Coagulation Analyzer Systems, 2008-2018
Table 5.14: European Revenues for POC Cardiac Markers, 2008-2018
Table 5.15: European Revenues for POC Substance/Drug Abuse Testing Market, 2008-2018
Table 5.16: European Revenues for POC Infectious Disease Testing Market, 2008-2018
Table 5.17: European Revenues for POC Urine Strip Testing Products Market, 2008-2018
Table 5.18: European Revenues for POC Pregnancy Testing Market, 2008-2018
Table 5.19: European Revenues for POC Fecal Occult Blood Testing Market, 2008-2018
Table 5.20: European Revenues for POC Cholesterol Testing Products Market, 2008-2018
Table 5.21: European Market Share Analysis, 2015
Table 6.1: Summary Analysis of Japanese, Chinese and Indian POCT Market, 2008-2018
Table 6.2: Summary Analysis of Japanese, Chinese and Indian Revenues for POC Blood Glucose Monitoring Systems, 2008-2018
Table 6.3: Summary Analysis of Japanese, Chinese and Indian Revenues for POC Blood Gas and Electrolyte Analyzers, 2008-2018
Table 6.4: Summary Analysis of Japanese, Chinese and Indian Revenues for POC Rapid Coagulation Analyzer Systems, 2008-2018
Table 6.5: Summary Analysis of Japanese, Chinese and Indian Revenues for POC Cardiac Marker Devices, 2008-2018
Table 6.6: Summary Analysis of Japanese, Chinese and Indian Revenues for POC Substance/Drug Abuse Testing Device Market, 2008-2018
Table 6.7: Summary Analysis of Japanese, Chinese and Indian Revenues for POC Infectious Disease Testing Devices Market, 2008-2018
Table 6.8: Summary Analysis of Japanese, Chinese and Indian Revenues for POC Urine Strip Testing Products Market, 2008-2018
Table 6.9: Summary Analysis of Japanese, Chinese and Indian Revenues for POC Pregnancy Testing Devices Market, 2008-2018
Table 6.10: Summary Analysis of Japanese, Chinese and Indian Revenues for POC Fecal Occult Testing Devices Market, 2008-2018
Table 6.11: Summary Analysis of Japanese, Chinese and Indian Revenues for POC Cholesterol Testing Products Market, 2008-2018
Table 6.12: Summary Analysis of Japanese, Chinese and Indian Market Shares, 2015
Table 6.13: Japanese Population and Aging Demographics Forecast, 2000-2050
Table 6.14: Japanese Revenues for POCT Market, 2008-2018
Table 6.15: Indian Revenues for POCT Market, 2008-2018
Table 6.16: Chinese Revenues for POCT Market, 2008-2018
Table 7.1: Summary Analysis of ROW POCT Market, 2008-2018
Table 7.2: Summary Analysis of ROW Revenues for POC Blood Glucose Monitoring Systems, 2008-2018
Table 7.3: Summary Analysis of ROW Revenues for POC Blood Gas and Electrolyte Analyzers, 2008-2018
Table 7.4: Summary Analysis of ROW Revenues for POC Rapid Coagulation Analyzer Systems, 2008-2018
Table 7.5: Summary Analysis of ROW Revenues for POC Cardiac Marker Devices, 2008-2018
Table 7.6: Summary Analysis of ROW Revenues for POC Substance/Drug Abuse Testing Device Market, 2008-2018
Table 7.7: Summary Analysis of ROW Revenues for POC Infectious Disease Testing Devices Market, 2008-2018
Table 7.8: Summary Analysis of ROW Revenues for POC Urine Strip Testing Products Market, 2008-2018
Table 7.9: Summary Analysis of ROW Revenues for POC Pregnancy Testing Devices Market, 2008-2018
Table 7.10: Summary Analysis of ROW Revenues for POC Fecal Occult Testing Devices Market, 2008-2018
Table 7.11: Summary Analysis of ROW Revenues for POC Cholesterol Testing Products Market, 2008-2018
Table 7.12: Summary Analysis of ROW Market Shares, 2015
Table 7.13: Summary Analysis of Argentinian Revenues for POCT Products Market, 2008-2018
Table 7.14: Summary Analysis of Australian Revenues for POCT Products Market, 2008-2018
Table 7.15: Summary Analysis of Brazilian Revenues for POCT Products Market, 2008-2018
Table 7.16: Summary Analysis of Canadian Revenues for POCT Products Market, 2008-2018
Table 7.17: Summary Analysis of Russian Revenues for POCT Products Market, 2008-2018
Table 7.18: Summary Analysis of Middle East Revenues for POCT Products Market, 2008-2018
Table 7.19: Summary Analysis of African Revenues for POCT Products Market, 2008-2018
Table 7.20: Summary Analysis of Asia (Other) Revenues for POCT Products Market, 2008-2018
Table 7.21: Summary Analysis of Latin America (Other) Revenues for POCT Products Market, 2008-2018
Table 8.1: Selected POC Blood Glucose and Blood Gas Meters Marketed for Professional Use, 2015
Table 8.2: POC HbA1c Testing Devices and Assays on the Market
Table 8.3: Global Revenues for Total Professional Blood Glucose Monitoring (Central Laboratory Testing and Hospital POC and POL), 2013-2019
Table 8.4: SWOT Analysis: Summary of Strengths, Weaknesses, Opportunities and Threats of the Glucose Point of Care Market
Table 8.5: Global Share of Glucose Testing Market by Company, 2015
Table 8.6: Selected POC Blood Gas and Electrolyte Analyzers, 2015
Table 8.7: Market Share of Blood Gas and Electrolyte POCT Diagnostic Testing Companies Worldwide, 2015
Table 8.8: SWOT Analysis: Summary of Strengths, Weaknesses, Opportunities and Threats in the Blood Gas and Electrolyte POC Market
Table 8.9: Hospital Locations of Point of Care Coagulation Testing
Table 8.10: Selected POC Rapid Coagulation Analyzers, 2015
Table 8.11: Actalyke XL
Table 8.12: Actalyke Mini
Table 8.13: Connectivity Modes for Leading Coagulation POCT Analyzers
Table 8.14: Market Share for Coagulation POCT Diagnostic Testing Companies, 2015
Table 8.15: Drivers for Point of Care Coagulation Testing
Table 8.16: Barriers for Point of Care Coagulation Testing
Table 8.17: SWOT Analysis: Summary of Strengths, Weaknesses, Opportunities and Threats in the Coagulation POC Market
Table 8.18: Selected POC Cardiac Biomarkers, 2016
Table 8.19: Market Share of Cardiac Marker POCT Diagnostic Testing Companies Worldwide, 2015
Table 8.20: POC Cardiac Marker Testing Market: Market Drivers Ranked in Order of Impact
Table 8.21: POC Cardiac Marker Testing Market: Market Restraints Ranked in Order of Impact
Table 8.22: SWOT Analysis: Summary of Strengths, Weaknesses, Opportunities and Threats in the Cardiac Marker POC Market
Table 8.23: Drug Testing Needs Tier I for Rapid Serum POCT in the Emergency Department
Table 8.24: Stat Urine Testing Drug Recommendations
Table 8.25: Selected POC Substance/Drug Abuse Testing Devices, 2016
Table 8.26: Selected POC Pregnancy Testing Devices, 2016
Table 8.27: Selected POC Fecal Occult Testing Devices, 2016
Table 8.28: ColoCARE Fecal Occult Blood Test
Table 8.29: SWOT Analysis: Summary of Strengths, Weaknesses, Opportunities and Threats in the Fecal Occult Blood POC Market
Table 8.30: Selected POC Infectious Disease Testing Devices and Assays, 2016
Table 8.31: Influenza Diagnostic Rapid Tests
Table 8.32: Selected POC Urine Strip Testing, 2016
Table 8.33: Selected POC Cholesterol Testing Devices, 2016
Table 8.34: AmniSure
Table 8.35: Competitive Factors Related to HIV Tests
Table 8.36: Global POCT Market for Rapid HIV Testing, 2011-2020
Table 8.37: Global POCT Share of HIV Testing Market, 2015
Table 8.38: Rapid HIV Immunoassay Tests
Table 9.1: POCT1-Compliant Connectivity POC Instruments
Table 9.2: POCT Clinical Outcomes in Diabetic Ketoacidosis
Table 9.3: POCT Clinical Outcomes in Arterial Blood-Gas Measurements
Table 9.4: POCT in Three Hospitals—Cost Analysis with Labor Included
Table 9.5: POCT versus Central Lab—Cost Analysis for Glucose Testing
Table 11.1: Common Genotype Techniques
Table 12.1: Applications for Wireless LAN Technology
Table 12.2: Customized Reports Must Support CAP and JCAHO Requirements
Table 14.1: Improvements in Achieving ED Operational Efficiency Using POCT
Table 14.2: Test Menu and TAT for ED
Table 14.3: Top Reasons Why POC Cardiac Marker Testing is Implemented in the ED
Table 14.4: Key Areas and Metrics that Hospitals Measure to Assess Efficiency of ED
Table 14.5: Estimates of Patient Costs by DRG

Note: Product cover images may vary from those shown
3 of 4

- A. Menarini Diagnostics
- ACON Laboratories, Inc.
- Abaxis, Inc.
- Abbott Laboratories
- Accriva Diagnostics
- AccuBioTech Co., Ltd.
- Acrongenomics
- Aerscher Diagnostics, LLC
- AgaMatrix
- Akers Biosciences, Inc.
- Alere
- Alfa Scientific Designs, Inc.
- Alliance International Co., Ltd.
- American Bio Medica Corporation
- Analyticon Biotechnologies AG
- Aquila Diagnostic Systems, Inc.
- ArcDia International Oyo Ltd.
- Arkray, Inc.
- Artron Laboratories, Inc.
- Ativa Medical Corporation
- Atlas Genetics Ltd.
- Atlas Link Biotech Co., Ltd.
- Atonomics A/S
- Audit Diagnostics
- Audit Diagnostics
- Augurix Diagnostics Ltd.
- Autobio Diagnostics Co., Ltd.
- Axxin
- Beckman Coulter (Danaher Corporation)
- BiOracle
- Bio-Rad Laboratories, Inc.
- BioFire Diagnostics, Inc.
- BioMedomics
- BioScan Screening Systems, Inc.
- Biocartis SA
- Biomerica, Inc.
- Biosensia Ltd.
- Calypte Biomedical Corporation
- Chembio Diagnostic, Inc.
- Cholestech
- Claros Diagnostics (OPKO Healthcare)
- Curetis AG
- Daktari Diagnostics
- Dexcom
- Diagnostics for All
- DxNA, LLC
- ERBA Diagnostics, Inc.
- EY Laboratoires, Inc.
- Echo Therapeutics, Inc.
- Enigma Diagnostics Ltd.
- Eurotrol
- Exalenz Bioscience
- GenBio
- Gentag, Inc.
- Great Basin Corporation
- Guided Therapeutics, Inc.
- Helena Laboratories
- Hema Diagnostic Systems, LLC
- Immunexpress Group
- Instrumentation Laboratory (IL)/Werfen Group
- Integrated Diagnostics
- Integrity Applications
- Jant Pharmacal Corporation
- Lein Applied Diagnostics
- LifeSign, LLC
- MBio Diagnostics, Inc.
- MedMira Laboratories
- Medica Corporation
- Medix Biochemica
- Menssana Research, Inc.
- Metaara Medical Technologies, Inc.
- Micronics
- New Horizons Diagnostics
- Nova Biomedical
- One Step Detect Associates, LLC
- OraSure Technologies, Inc.
- Orion Diagnostica
- Philips Business Group EBA
- Polymedco, Inc.
- Polymer Technology Systems, Inc.
- Prima Biomedical Company
- Qualigen
- QuantuMDx Group
- Quest Diagnostics, Inc.
- Quidel Corporation
- Radiometer Medical
- Response Biomedical Corp.
- Roche Diagnostics
- Savyon Diagnostics
- Seegene
- Sekisui Diagnostics, LLC
- Senseonics
- Shanghai Ruicare Medical Co., Ltd.
- Shenzhen Fitconn Technology Co., Ltd.
- Shionogi & Co., Ltd.
- Siemens AG
- Siloam Biosciences, Inc.
- Spectral Diagnostics, Inc.
- StatSure Diagnostic Systems, Inc.
- Telcare
- Trinity Biotech Plc
- Venaxis, Inc.
- Veredus Laboratories Pte Ltd.
- Väsamed, Inc.
- Wave 80 Biosciences
- bioLytical Laboratories
- bioMérieux

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-10 user licence, allowing up to ten users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • General Electric (GE) Company
  • IDEXX Laboratories, Inc.
  • Novartis AG
  • Philips N.V.
  • Quidel Corporation
  • Bio-Rad Laboratories, Inc.